Events

Events Search and Views Navigation

Event Views Navigation

Today

  • Hemophilia A – Hudson, NY

    Hudson Cancer Center 69 Prospect Ave., Hudson, NY, United States

    This case-based live activity will cover the treatment and management of patients with hemophilia A

  • HCC GR 45 – East Meadow, NY

    Nassau University Medical Center 2201 Hempstead Turnpike, East Meadow, NY, United States

    This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).

  • Atopic Derm – Miami, FL

    This activity is intended educate PCPs, NPs, and PAs about diagnosing, treating, and managing atopic dermatitis in pediatric patients.

  • axSpA GR – Chicago, IL

    Saint Anthony Hospital 2875 W 19th Street, Chicago, IL, United States

    This activity is primarily designed for U.S.-based members of multidisciplinary teams involved in the management of patients with Axial Spondyloarthritis.

  • Atopic Derm – Gold Beach, OR

    This activity is intended educate PCPs, NPs, and PAs about diagnosing, treating, and managing atopic dermatitis in pediatric patients.

  • CDK 4/6 Inhibitors in HR+/HER2- Breast Cancer – Ayer, MA

    Nashoba Valley Medical Center 200 Groton Rd., Ayer, MA, United States

    This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.

  • HCC GR 45 – Hudson, NY

    This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).

  • Atopic Derm – Prescott, AZ

    This activity is intended educate PCPs, NPs, and PAs about diagnosing, treating, and managing atopic dermatitis in pediatric patients.

  • axSpA GR – San Francisco, CA

    This activity is primarily designed for U.S.-based members of multidisciplinary teams involved in the management of patients with Axial Spondyloarthritis.

  • HCC GR 45 – Brooklyn, NY

    SUNY Downstate Medical Center 450 Clarkson Ave, Brooklyn, NY, United States

    This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).

  • CDK 4/6 Inhibitors in HR+/HER2- Breast Cancer – East Meadow, NY

    Nassau University Medical Center 2201 Hempstead Turnpike, East Meadow, NY, United States

    This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.

  • CDK 4/6 Inhibitors in HR+/HER2- Breast Cancer – Northfield, MN

    Northfield Hospital and Clinics 2000 North Ave, Northfield, MN, United States

    This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.